爱普股份签订关于挪亚圣诺(太仓)生物科技有限公司股权收购意向协议

Core Viewpoint - Aipu Co., Ltd. (603020.SH) has signed an equity acquisition intention agreement with Noah Sanno Europe to acquire 100% equity of Noah Sanno (Taicang) Biotechnology Co., Ltd. to enhance its strategic layout and achieve high-quality development [1] Group 1: Acquisition Details - The acquisition will occur in two phases: Aipu will first acquire 80% of the target company, followed by the remaining equity after the performance commitment period [1] - The final transaction price will be determined based on due diligence, auditing, and evaluation results, subject to negotiation between both parties [1] Group 2: Target Company Overview - The target company, established in 2009 and located in Taicang, Jiangsu, specializes in the research, production, and sales of Omega-3 raw materials, including fish oil and algae oil [1] - Its main products include refined fish oil and concentrated fish oil, and it has built a strong customer base comprising globally recognized health supplement, functional food and beverage, infant nutrition, and pet food clients [1]